Thailand Breast Cancer Diagnostics Market to 2032
Overview
The Thailand Breast Cancer Diagnostics Market is expected to reach a 175.29 USD Million by 2032 and is projected to grow at a CAGR of 13.34% from 2025 to 2032.
Thailand Breast Cancer Diagnostics Market 2018-2032 USD Million
Thailand Breast Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 80.48 USD Million
- Projected Market Size (2032): 175.29 USD Million
- CAGR (2025-2032): 13.34%
Key Findings of Thailand Breast Cancer Diagnostics Market
- The Thailand Breast Cancer Diagnostics Market was valued at 175.29 USD Million in 2024.
- The Thailand Breast Cancer Diagnostics Market is likely to grow at a CAGR of 13.34% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Invasive Ductal Carcinoma in Type Segment accounted for the largest share of the market with a revenue of 56.11 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 14.86% during the forecast period from 2024 to 2032.
Thailand Breast Cancer Diagnostics Market Scope
- Others
- Research & Academic Institutes
- Clinics
- Diagnostic Centers
- Hospitals
- Others
- Retail Sales
- Direct Tenders
- Metastatic Breast Cancer
- Inflammatory Breast Cancer
- Ductal Carcinoma In Situ
- Invasive Ductal Carcinoma
- Others
- Blood Test
- Genomic Test
- Biopsy
- Imaging
Thailand Breast Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 80.48 USD Million |
| Market Value in 2032 | 175.29 USD Million |
| CAGR (2025-2032) | 13.34% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Type,Test |
Regional Insights:
-
Leading Market (2024-2032): Thailand, leading in terms of revenue 80.48 USD Million in 2024
- Key Country: Thailand, leading in terms of revenue with value of 80.48 USD Million in 2024.
Segments and Scope
-
Thailand Breast Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Thailand Breast Cancer Diagnostics Market to 2032 with a revenue of 35.51 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Thailand Breast Cancer Diagnostics Market to 2032 with a Growth rate of 14.86 % in forecast period 2025-2032.
-
Thailand Breast Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Thailand Breast Cancer Diagnostics Market to 2032 with a revenue of 53.68 USD Million in the year 2024.
- Direct Tenders is the Fastest growing segment in Thailand Breast Cancer Diagnostics Market to 2032 with a Growth rate of 13.95 % in forecast period 2025-2032.
-
Thailand Breast Cancer Diagnostics Market to 2032, By Type
- Invasive Ductal Carcinoma is the largest segment in Thailand Breast Cancer Diagnostics Market to 2032 with a revenue of 56.11 USD Million in the year 2024.
- Invasive Ductal Carcinoma is the Fastest growing segment in Thailand Breast Cancer Diagnostics Market to 2032 with a Growth rate of 13.80 % in forecast period 2025-2032.
-
Thailand Breast Cancer Diagnostics Market to 2032, By Test
- Imaging is the largest segment in Thailand Breast Cancer Diagnostics Market to 2032 with a revenue of 35.50 USD Million in the year 2024.
- Imaging is the Fastest growing segment in Thailand Breast Cancer Diagnostics Market to 2032 with a Growth rate of 14.44 % in forecast period 2025-2032.
Thailand Breast Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Koninklijke Philips N.V. | |||
| Abbott | |||
| Hologic, Inc. | |||
| Exact Sciences Corporation | |||
| F. Hoffmann-La Roche Ltd. | |||
Thailand Breast Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Thailand Breast Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Thailand Breast Cancer Diagnostics Market Scope
- Others
- Research & Academic Institutes
- Clinics
- Diagnostic Centers
- Hospitals
- Others
- Retail Sales
- Direct Tenders
- Metastatic Breast Cancer
- Inflammatory Breast Cancer
- Ductal Carcinoma In Situ
- Invasive Ductal Carcinoma
- Others
- Blood Test
- Genomic Test
- Biopsy
- Imaging
Frequently Asked Questions
Thailand Breast Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.